Market Research Logo

Global Obesity Market and Competitive Landscape – 2017

Global Obesity Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Obesity Market and Competitive Landscape – 2017, provides comprehensive insights into Obesity pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Obesity market size and drug sales. This research also provides insights into Obesity epidemiology and late stage pipeline.
The report is classified into twelve sections – Obesity overview with definitions, symptoms, etiology, diagnosis, treatment options; Obesity pipeline insights covering late stage clinical trials pipeline; Obesity prevalence trends by countries; Obesity market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Obesity pipeline: Find out the drugs in clinical trials for Obesity by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Obesity epidemiology: Find out the prevalence of Obesity by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Obesity products: Identify key products marketed and prescribed for Obesity by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Obesity market size: Find out the market size for Obesity drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Obesity drug sales: Find out the sales of Obesity drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Obesity drugs sales forecast: Sales forecast for Obesity drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Obesity market share analysis: Find out the market shares of Obesity drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Obesity drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Obesity market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Obesity market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Obesity: Disease Overview
1.1. Obesity Symptoms
1.2. Obesity Etiology
1.3. Obesity Diagnosis
1.4. Obesity Treatment Options
2. Obesity Pipeline Insights
2.1. Obesity Phase 3 Clinical Trials
2.2. Obesity Phase 2 Clinical Trials
2.3. Obesity Phase 1 Clinical Trials
3. Obesity Epidemiology Analysis
4. US Obesity Market Insights
4.1. Marketed Products for Obesity in US
4.2. US Obesity Market Size & Forecast
4.3. US Obesity Product Sales Forecast
4.4. US Obesity Market Share Analysis
5. Germany Obesity Market Insights
5.1. Marketed Products for Obesity in Germany
5.2. Germany Obesity Market Size & Forecast
5.3. Germany Obesity Product Sales Forecast
5.4. Germany Obesity Market Share Analysis
6. France Obesity Market Insights
6.1. Marketed Products for Obesity in France
6.2. France Obesity Market Size & Forecast
6.3. France Obesity Product Sales Forecast
6.4. France Obesity Market Share Analysis
7. Italy Obesity Market Insights
7.1. Marketed Products for Obesity in Italy
7.2. Italy Obesity Market Size & Forecast
7.3. Italy Obesity Product Sales Forecast
7.4. Italy Obesity Market Share Analysis
8. Spain Obesity Market Insights
8.1. Marketed Products for Obesity in Spain
8.2. Spain Obesity Market Size & Forecast
8.3. Spain Obesity Product Sales Forecast
8.4. Spain Obesity Market Share Analysis
9. UK Obesity Market Insights
9.1. Marketed Products for Obesity in UK
9.2. UK Obesity Market Size & Forecast
9.3. UK Obesity Product Sales Forecast
9.4. UK Obesity Market Share Analysis
10. Europe Obesity Market Insights
10.1. Europe Obesity Market Size & Forecast
10.2. Europe Obesity Product Sales Forecast
10.3. Europe Obesity Market Share Analysis
11. Japan Obesity Market Insights
11.1. Marketed Products for Obesity in Japan
11.2. Japan Obesity Market Size & Forecast
11.3. Japan Obesity Product Sales Forecast
11.4. Japan Obesity Market Share Analysis
12. Global Obesity Market Insights
12.1. Global Obesity Market Size & Forecast
12.2. Global Obesity Product Sales Forecast
12.3. Global Obesity Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Obesity Phase 3 Clinical Trials, Global, 2017
Table 2: Obesity Phase 2 Clinical Trials, Global, 2017
Table 3: Obesity Phase 1 Clinical Trials, Global, 2017
Table 4: Obesity Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Obesity in US, 2017
Table 6: US Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Obesity Product Sales ($mn), 2012 - 2021
Table 8: US Obesity Market Trends, 2012 - 2021
Table 9: Marketed Products for Obesity in Germany, 2017
Table 10: Germany Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Obesity Product Sales ($mn), 2012 - 2021
Table 12: Germany Obesity Market Trends, 2012 - 2021
Table 13: Marketed Products for Obesity in France, 2017
Table 14: France Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Obesity Product Sales ($mn), 2012 - 2021
Table 16: France Obesity Market Trends, 2012 - 2021
Table 17: Marketed Products for Obesity in Italy, 2017
Table 18: Italy Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Obesity Product Sales ($mn), 2012 - 2021
Table 20: Italy Obesity Market Trends, 2012 - 2021
Table 21: Marketed Products for Obesity in Spain, 2017
Table 22: Spain Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Obesity Product Sales ($mn), 2012 - 2021
Table 24: Spain Obesity Market Trends, 2012 - 2021
Table 25: Marketed Products for Obesity in UK, 2017
Table 26: UK Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Obesity Product Sales ($mn), 2012 - 2021
Table 28: UK Obesity Market Trends, 2012 - 2021
Table 29: Europe Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Obesity Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Obesity in Japan, 2017
Table 32: Japan Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Obesity Product Sales ($mn), 2012 - 2021
Table 34: Japan Obesity Market Trends, 2012 - 2021
Table 35: Global Obesity Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Obesity Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Obesity Pipeline by Phase (%), Global, 2017
Figure 2: Obesity Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Obesity Market Size ($mn), 2012 - 2021
Figure 4: US Obesity Product Sales ($mn), 2012 - 2021
Figure 5: US Obesity Market Share by Products (%), 2016
Figure 6: US Obesity Market - Future Market Share (%), 2021
Figure 7: Germany Obesity Market Size ($mn), 2012 - 2021
Figure 8: Germany Obesity Product Sales ($mn), 2012 - 2021
Figure 9: Germany Obesity Market Share by Products (%), 2016
Figure 10: Germany Obesity Market - Future Market Share (%), 2021
Figure 11: France Obesity Market Size ($mn), 2012 - 2021
Figure 12: France Obesity Product Sales ($mn), 2012 - 2021
Figure 13: France Obesity Market Share by Products (%), 2016
Figure 14: France Obesity Market - Future Market Share (%), 2021
Figure 15: Italy Obesity Market Size ($mn), 2012 - 2021
Figure 16: Italy Obesity Product Sales ($mn), 2012 - 2021
Figure 17: Italy Obesity Market Share by Products (%), 2016
Figure 18: Italy Obesity Market - Future Market Share (%), 2021
Figure 19: Spain Obesity Market Size ($mn), 2012 - 2021
Figure 20: Spain Obesity Product Sales ($mn), 2012 - 2021
Figure 21: Spain Obesity Market Share by Products (%), 2016
Figure 22: Spain Obesity Market - Future Market Share (%), 2021
Figure 23: UK Obesity Market Size ($mn), 2012 - 2021
Figure 24: UK Obesity Product Sales ($mn), 2012 - 2021
Figure 25: UK Obesity Market Share by Products (%), 2016
Figure 26: UK Obesity Market - Future Market Share (%), 2021
Figure 27: Europe Obesity Market Size ($mn), 2012 - 2021
Figure 28: Europe Obesity Product Sales ($mn), 2012 - 2021
Figure 29: Europe Obesity Market Share by Products (%), 2016
Figure 30: Europe Obesity Market - Future Market Share (%), 2021
Figure 31: Japan Obesity Market Size ($mn), 2012 - 2021
Figure 32: Japan Obesity Product Sales ($mn), 2012 - 2021
Figure 33: Japan Obesity Market Share by Products (%), 2016
Figure 34: Japan Obesity Market - Future Market Share (%), 2021
Figure 35: Global Obesity Market Size ($mn), 2012 - 2021
Figure 36: Global Obesity Product Sales ($mn), 2012 - 2021
Figure 37: Global Obesity Market Share by Products (%), 2016
Figure 38: Global Obesity Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report